These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 18971540

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
    Fujisawa M, Yorikane R, Matsuoka Y, Koike H, Ueno K.
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):63-9. PubMed ID: 23288106
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine.
    Yamagishi T.
    Hypertens Res; 2006 Oct; 29(10):767-73. PubMed ID: 17283863
    [Abstract] [Full Text] [Related]

  • 24. Combination therapy of olmesartan and azelnidipine inhibits sympathetic activity associated with reducing oxidative stress in the brain of hypertensive rats.
    Shinohara K, Hirooka Y, Ogawa K, Kishi T, Yasukawa K, Utsumi H, Sunagawa K.
    Clin Exp Hypertens; 2012 Oct; 34(6):456-62. PubMed ID: 22471901
    [Abstract] [Full Text] [Related]

  • 25. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
    Matsubara M, Akizuki O, Ikeda J, Saeki K, Yao K, Sasaki K.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):201-13. PubMed ID: 18048030
    [Abstract] [Full Text] [Related]

  • 26. Beneficial effects of combination therapy with olmesartan and azelnidipine in murine polycystic kidneys.
    Tanifuji C, Suzuki Y, Geot WM, Horikoshi S, Takahashi H, Tomino Y.
    Kidney Blood Press Res; 2009 Feb 02; 32(4):239-49. PubMed ID: 19752573
    [Abstract] [Full Text] [Related]

  • 27. Comparative effects of olmesartan and azelnidipine on atrial structural remodeling in spontaneously hypertensive rats.
    Okamura K, Ito M, Tanaka K, Chinushi M, Adachi T, Mitsuma W, Hirono S, Nakazawa M, Kodama M, Aizawa Y.
    Pharmacology; 2009 Feb 02; 83(6):360-6. PubMed ID: 19440002
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells.
    Matsui T, Yamagishi S, Nakamura K, Kikuchi S, Inoue H.
    Drugs Exp Clin Res; 2005 Feb 02; 31(5-6):215-9. PubMed ID: 16425978
    [Abstract] [Full Text] [Related]

  • 31. Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice.
    Nakano K, Egashira K, Ohtani K, Gang Z, Iwata E, Miyagawa M, Sunagawa K.
    Atherosclerosis; 2008 Jan 02; 196(1):172-179. PubMed ID: 17481639
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats.
    Omote Y, Deguchi K, Kono S, Liu W, Kurata T, Hishikawa N, Yamashita T, Ikeda Y, Abe K.
    J Neurosci Res; 2014 Oct 02; 92(10):1330-7. PubMed ID: 24839960
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of antihypertensive drugs and exercise training on insulin sensitivity in spontaneously hypertensive rats.
    Guo Q, Minami N, Mori N, Nagasaka M, Ito O, Kurosawa H, Kanazawa M, Kohzuki M.
    Hypertens Res; 2008 Mar 02; 31(3):525-33. PubMed ID: 18497473
    [Abstract] [Full Text] [Related]

  • 40. Inhibitory effects of losartan and azelnidipine on augmentation of blood pressure variability induced by angiotensin II in rats.
    Jiang D, Kawagoe Y, Kuwasako K, Kitamura K, Kato J.
    Eur J Pharmacol; 2017 Jul 05; 806():91-95. PubMed ID: 28419822
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.